FIELD: medicine, therapy, immunology. SUBSTANCE: method involves administration to patient the preparation of proteoselenium complex as an alcoholic solution containing 3-6 mcg of selenium per 1 ml. Before administration the solution containing selenium and/or calcium ions is added to the preparation of proteoselenium complex. EFFECT: enhanced effectiveness of therapy, decreased dose of preparation. 5 cl, 2 ex
Authors
Dates
2001-04-27—Published
2000-09-26—Filed